Market revenue in 2022 | USD 342.4 million |
Market revenue in 2030 | USD 796.9 million |
Growth rate | 11.1% (CAGR from 2022 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Services |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Abcam PLC, Enzon Pharmaceuticals Inc, Merck KGaA, Caribou Biosciences Inc Ordinary Shares, NOF Corp, Caleres Inc, Creative PEGWorks, Aurigene Pharmaceutical Services, Laysan Bio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pegylated proteins market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.67% in 2022. Horizon Databook has segmented the Europe pegylated proteins market based on consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pegylated proteins market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pegylated proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account